Biodesix, Inc. splits its revenue into 2 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Diagnostic Tests at $23.1 million, 96% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
105
|
24
|
27
|
26
|
29
|
22
|
20
|
18
|
20
|
| Diagnostic Tests |
96
+34.5%
share 91.1%
|
23
+16.2%
share 95.9%
|
25
+41.6%
share 94.4%
|
22
+36.6%
share 87.2%
|
25
+46.2%
share 87.5%
|
20
share 91.1%
|
18
share 89.4%
|
16
share 90.9%
|
17
share 84.2%
|
| Development Services |
9
+5.0%
share 8.9%
|
1
-49.0%
share 4.1%
|
2
-28.7%
share 5.6%
|
3
+98.8%
share 12.8%
|
4
+11.9%
share 12.5%
|
2
share 8.9%
|
2
share 10.6%
|
2
share 9.1%
|
3
share 15.8%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BDSX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Louisville, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1439725
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.